Welcome to our dedicated page for Isramco SEC filings (Ticker: ISRL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Israel Acquisitions Corp (ISRL) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a Nasdaq‑listed special purpose acquisition company. As a SPAC, Israel Acquisitions Corp reports on its trust account arrangements, extensions of its business combination deadline, proposed mergers with target companies, and developments affecting its listing status.
Through its Forms 8‑K, investors can review material events such as the entry into and amendment of the business combination agreement with Gadfin Ltd., an Israeli technology company focused on long‑range, all‑weather drone delivery for essential cargo. These filings outline the planned structure involving a new Israeli holding company (NewPubco), merger subsidiaries, and the resulting ownership of Gadfin and Israel Acquisitions Corp. Earlier 8‑K filings also document the now‑terminated business combination agreement with Pomvom Ltd. and the mutual termination and release agreement between the parties.
Proxy statements on Schedule 14A detail proposals to amend Israel Acquisitions Corp’s memorandum and articles of association and its investment management trust agreement. These documents explain how the company can extend the deadline for completing an initial business combination, the required deposits into the trust account for each extension, and the redemption rights available to public shareholders.
More recent filings include Nasdaq‑related disclosures. A Form 8‑K dated January 13, 2026 reports that Nasdaq issued a press release announcing its plan to delist ISRL’s Class A ordinary shares, units, and warrants, with the delisting to become effective ten days after Nasdaq files a Form 25. Other filings describe a Nasdaq deficiency notice regarding market value of listed securities and the company’s options to regain compliance or consider a transfer to another Nasdaq market tier.
On Stock Titan, these filings are updated as they appear on EDGAR, and AI‑powered summaries help explain the key points from lengthy documents such as proxy statements and business combination agreements. Users can quickly see which filings relate to the Gadfin transaction, which address extensions and trust amendments, and which concern Nasdaq listing and delisting procedures, without having to parse every technical detail themselves.
Israel Acquisitions Corp reported that Nasdaq plans to delist all of its publicly traded securities. According to a Nasdaq press release issued under Nasdaq Listing Rule 5830 and Exchange Act Rule 12d2-2, Nasdaq intends to delist the company’s Class A ordinary shares, its units (each consisting of one Class A ordinary share and one redeemable warrant), and its redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of
The delisting will become effective ten days after Nasdaq files a Form 25 to remove the securities from listing. The Nasdaq press release is being furnished as an exhibit and is not deemed filed for liability purposes under the Exchange Act.
Israel Acquisitions Corp entered into a waiver with its sponsor that eliminates certain administrative service fees. The sponsor agreed to waive the $10,000 per month it was entitled to receive until the company completes an initial business combination or is liquidated, as well as $240,000 of administrative fees that had already accrued.
This change reduces the company’s ongoing overhead and forgives past amounts owed to its sponsor, helping preserve cash within the special purpose acquisition company structure.
Israel Acquisitions Corp is asking shareholders at a January 16, 2026 extraordinary meeting to approve changes that would extend the deadline to complete a business combination. The board proposes amending the company’s charter and trust agreement to allow up to 12 additional one‑month extensions beyond the current January 18, 2026 termination date, pushing the possible deadline to January 18, 2027. For each monthly extension, the sponsor or its affiliates may deposit into the trust account the lesser of $5,000 or $0.05 per public share, in exchange for a non‑interest‑bearing promissory note. Public shareholders can redeem their shares for cash in connection with the vote; as of the December 19, 2025 record date, the trust held about $9.9 million, or roughly $12.72 per public share, versus a $12.36 OTC market price. The company has a signed business combination agreement with Gadfin Ltd. but notes there is no assurance the deal will close, and its shares have been delisted from Nasdaq and now trade on the OTC Markets.
Israel Acquisitions Corp (ISRL) filed a Form 8-K announcing a corporate presentation dated November 3, 2025. The presentation, attached as Exhibit 99.1, is intended for use in communications with potential investors and is being filed pursuant to Rule 425 of the Securities Act.
The company notes that any website links included are inactive textual references and are not incorporated by reference. The report and Exhibit 99.1 contain forward-looking statements based on current expectations, which are subject to risks and uncertainties as described in the company’s SEC filings.
Israel Acquisitions Corp (ISRL) reported that on November 3, 2025 it finalized a corporate presentation for use with potential investors and made it available as Exhibit 99.1. The materials are being filed pursuant to Rule 425 of the Securities Act and are incorporated by reference.
The company notes that any website references in the materials are inactive textual references and not part of the filing. The presentation and this report include forward-looking statements subject to risks described in the company’s SEC reports. ISRL’s securities trade on Nasdaq: ISRLU (units), ISRL (Class A ordinary shares), and ISRLW (redeemable warrants).
Israel Acquisitions Corp (ISRL) disclosed a Letter Agreement with Gadfin and an Advisory Agreement with BTIG tied to ISRL’s proposed business combination with Gadfin. BTIG will provide strategic and capital markets advisory services and, as compensation, receive $500,000 in cash (payable from the trust) and 100,000 Class A shares of ISRL immediately prior to closing, which will be exchanged for 100,000 NewPubco shares valued at $10.00 per share upon consummation.
In exchange, BTIG waived its deferred underwriting commission, conditioned on payment of the advisory fee and closing. The Sponsor agreed to forfeit additional ISRL shares equal to the number issued to BTIG. Gadfin consented to the advisory arrangement and waived its BCA termination right related to obtaining the deferred fee waiver. Before closing, NewPubco will arrange a Public Offering of Securities Insurance to cover any BTIG indemnification claims. BTIG also received a three‑year ROFR to lead the next SPAC IPO by ISRL or the Sponsor and may terminate the agreement at any time, forfeiting both the advisory fee and the deferred commission.
FAQ
What is the current stock price of Isramco (ISRL)?
What is the market cap of Isramco (ISRL)?
